AAAAAA

   
Results: 1-9 |
Results: 9
INCREASED MORTALITY FOLLOWING CMV INFECTION IN PATIENTS TRANSPLANTED FOR HCV - RESULTS OF THE NIDDK LIVER-TRANSPLANTATION DATABASE
Authors: CHARLTON M SEABERG E WIESNER R PAYA C EVERHART J ZETTERMAN R LAKE J HOOFNAGLE J
Citation: M. Charlton et al., INCREASED MORTALITY FOLLOWING CMV INFECTION IN PATIENTS TRANSPLANTED FOR HCV - RESULTS OF THE NIDDK LIVER-TRANSPLANTATION DATABASE, Hepatology, 28(4), 1998, pp. 729-729
PREDICTORS OF PATIENT AND GRAFT-SURVIVAL FOLLOWING LIVER-TRANSPLANTATION FOR HEPATITIS-C
Authors: CHARLTON M SEABERG E WIESNER R EVERHART J ZETTERMAN R LAKE J DETRE K HOOFNAGLE J
Citation: M. Charlton et al., PREDICTORS OF PATIENT AND GRAFT-SURVIVAL FOLLOWING LIVER-TRANSPLANTATION FOR HEPATITIS-C, Hepatology, 28(3), 1998, pp. 823-830
INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-B IN CHILDREN - A MULTINATIONAL RANDOMIZED CONTROLLED TRIAL
Authors: SOKAL EM CONJEEVARAM HS ROBERTS EA ALVAREZ F BERN EM GOYENS P ROSENTHAL P LACHAUX A SHELTON M SARLES J HOOFNAGLE J
Citation: Em. Sokal et al., INTERFERON-ALPHA THERAPY FOR CHRONIC HEPATITIS-B IN CHILDREN - A MULTINATIONAL RANDOMIZED CONTROLLED TRIAL, Gastroenterology, 114(5), 1998, pp. 988-995
INTERFERON-ALFA FOR TREATMENT OF PEDIATRIC CHRONIC HEPATITIS-B - A RANDOMIZED CONTROLLED MULTICENTER TRIAL
Authors: SOKAL EM CONJEEVARAM H ROBERTS EA ALVAREZ F BERN EM GOYENS P ROSENTHAL P LACHAUX A SHELTON M SARLES J ALBRECHT J HOOFNAGLE J LETALLEC C BURY F DEBRAY D MOLLESTON J DABADIE A SCHREIBER RA ZWIENER RJ DEPRETTERE A VEEREMAN G KLEINER D CORNU C
Citation: Em. Sokal et al., INTERFERON-ALFA FOR TREATMENT OF PEDIATRIC CHRONIC HEPATITIS-B - A RANDOMIZED CONTROLLED MULTICENTER TRIAL, Hepatology, 26(4), 1997, pp. 1193-1193
PRIMARY BILIARY-CIRRHOSIS CLINICAL RESEARCH SINGLE-TOPIC CONFERENCE
Authors: LINDOR KD HOOFNAGLE J MADDREY WC MACKAY IR DICKSON ER
Citation: Kd. Lindor et al., PRIMARY BILIARY-CIRRHOSIS CLINICAL RESEARCH SINGLE-TOPIC CONFERENCE, Hepatology, 23(3), 1996, pp. 639-644
SYMPTOMS AND LIVER HISTOLOGY IN BLOOD-DONORS WITH HEPATITIS-C VIRUS-INFECTION
Authors: CONRYCANTILENA C SHAKIL AO VANRADEN M MELPOLDER JC KLEINER D HOOFNAGLE J ALTER HJ GIBBLE J NASS C NESS P
Citation: C. Conrycantilena et al., SYMPTOMS AND LIVER HISTOLOGY IN BLOOD-DONORS WITH HEPATITIS-C VIRUS-INFECTION, Transfusion, 36(9), 1996, pp. 202-202
ROUTES OF INFECTION, VIREMIA, AND LIVER-DISEASE IN BLOOD-DONORS FOUNDTO HAVE HEPATITIS-C VIRUS-INFECTION
Authors: CONRYCANTILENA C VANRADEN M GIBBLE J MELPOLDER J SHAKIL AO VILADOMIU L CHEUNG L DIBISCEGLIE A HOOFNAGLE J SHIH JW KASLOW R NESS P ALTER HJ
Citation: C. Conrycantilena et al., ROUTES OF INFECTION, VIREMIA, AND LIVER-DISEASE IN BLOOD-DONORS FOUNDTO HAVE HEPATITIS-C VIRUS-INFECTION, The New England journal of medicine, 334(26), 1996, pp. 1691-1696
SEVERE TOXICITY OF FIALURIDINE (FIAU) - REPLY
Authors: HOOFNAGLE J MCKENZIE R STRAUS S
Citation: J. Hoofnagle et al., SEVERE TOXICITY OF FIALURIDINE (FIAU) - REPLY, The New England journal of medicine, 334(17), 1996, pp. 1137-1137
THE 5' END OF HCV - CHARACTERIZATION BY END-TO-END RNA LIGATION-MEDIATED POLYMERASE CHAIN-REACTION
Authors: SALLIE R CHIA SC HOOFNAGLE J DIBISCEGLIE AM FEINSTONE SM
Citation: R. Sallie et al., THE 5' END OF HCV - CHARACTERIZATION BY END-TO-END RNA LIGATION-MEDIATED POLYMERASE CHAIN-REACTION, Hepatology, 18(4), 1993, pp. 10000078-10000078
Risultati: 1-9 |